Table 1 Baseline characteristics of the included patients (N = 161)
Age (years) | |
Mean ± SD | 62 ± 11 |
Median (min–max) | 63 (18–86) |
Sex (%) | |
Male | 108 (67.1%) |
Female | 53 (32.9%) |
BMI (kg/m2) | |
Mean ± SD | 25.4 ± 4.5 |
Median (quartile 25–75) | 24.9 (22.6–27.7) |
Cirrhosis (%) | |
Yes | 135 (83.9%) |
No | 26 (16.1%) |
Child–Pugh (%)† | |
A5 | 111 (82.2%) |
A6 | 17 (12.6%) |
B7 | 7 (5.2%) |
Preoperative MELD | |
Mean ± SD | 8 ± 3 |
Median (quartile 25–75) | 8 (7–9) |
Portal hypertension (%) | |
Yes | 43 (26.7%) |
No | 92 (73.3%) |
Esophageal varices (%) | |
Yes | 22 (13.7%) |
No | 21 (86.3%) |
Hemoglobin (g/dL) | |
Mean ± SD | 13.7 ± 3.8 |
Median (quartile 25–75) | 13.7 (12.6–14.9) |
Platelet count (/mm3) | |
Mean ± SD | 186,410 ± 97,208 |
Median (quartile 25–75) | 170,000 (118,000–230,000) |
Bilirubin (g/dL) | |
Mean ± SD | 0.72 ± 0.22 |
Median (quartile 25–75) | 0.65 (0.47–0.89) |
Aspartate aminotransferase (AST, U/L) | |
Mean ± SD | 62.0 ± 61.0 |
Median (quartile 25–75) | 42.0 (28.0–68.0) |
Alanine aminotransferase (ALT, U/L) | |
Mean ± SD | 54.7 ± 51.0 |
Median (quartile 25–75) | 38.0 (25.0–69.0) |
INR | |
Mean ± SD | 1.1 ± 0.1 |
Median (quartile 25–75) | 1.1 (1.0–1.2) |
Creatinine (mg/dL) | |
Mean ± SD | 1.0 ± 1.0 |
Median (quartile 25–75) | 0.9 (0.7–1.1) |
Alpha-fetoprotein (ng/mL) | |
Mean ± SD | 2483.1 ± 9906.5 |
Median (quartile 25–75) | 19.0 (4.7–172.7) |
Albumin (g/dL) | |
Mean ± SD | 4.0 ± 0.3 |
Median (quartile 25–75) | 4.1 (3.7–4.5) |
Neutrophil count (/mm3) | |
Mean ± SD | 3601 ± 3465 |
Median (quartile 25–75) | 3300 (2300–4410) |
Lymphocyte count (/mm3) | |
Mean ± SD | 1869 ± 773 |
Median (quartile 25–75) | 1700 (1300–2300) |
Monocyte count (/mm3) | |
Mean ± SD | 575 ± 308 |
Median (quartile 25–75) | 510 (400–700) |
NLR | |
Mean ± SD | 2.3 ± 2.2 |
Median (quartile 25–75) | 1.9 (1.4–2.6) |
PLR | |
Mean ± SD | 115.4 ± 89.4 |
Median (quartile 25–75) | 96.2 (67.0–144.4) |
MLR | |
Mean ± SD | 3.8 ± 2.0 |
Median (quartile 25–75) | 3.5 (2.4–4.6) |
Tumor size (mm) | |
Mean ± SD | 62.0 ± 50.7 |
Median (quartile 25–75) | 42 (29.0–80.0) |
Number of nodules | |
Mean ± SD | 1.23 ± 0.7 |
Median (quartile 25–75) | 1.0 (1.0–1.0) |
Tumor grade (%) | |
Well differentiated | 9 (5.6%) |
Moderately differentiated | 104 (64.6%) |
Poor differentiated | 28 (17.4%) |
Unavailable | 20 (12.4%) |
Satellite nodules (%) | |
Yes | 40 (24.8%) |
No | 121 (75.2%) |
Vascular invasion (%)†† | |
Yes | 82 (50.9%) |
No | 75 (43.8%) |
Unavailable | 4 (2.5%) |